governmentEvidence level AIndependent
Evidence pageSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception
US Food and Drug Administration (CBER)
accessed Nov 12, 2026Updated Nov 12, 2026
Original source
fda.gov
Verification
| Verification | Independent of the subject |
| Evidence level | A · Government / regulator |
| Independent | Independent of the subject |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (19)
FactAutologous Fat: FDA guidance on exception scope = CBER final guidance, 'Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers', issued November 2017FactBreast Fat Grafting: Relevant FDA guidance = Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionAnswerCan your body reject your own fat after a fat transfer?AnswerHow much transferred autologous fat survives?AnswerWhich body area is best for harvesting fat for grafting?AnswerIs autologous fat the same as SVF or stem cells?AnswerWhat are the risks of autologous fat transfer?Answer일반 지방이식과 SVF 지방이식의 차이는 무엇인가요?Answer일반 지방이식과 줄기세포 지방이식의 차이는 시술 과정 중 어느 단계에서 생기나요?Answer일반 지방이식과 줄기세포 지방이식 차이, 줄기세포 치료와 같은 뜻인가요?AnswerSVF 얼굴성형, 어떤 원리의 시술이며 효과 근거는 어느 정도인가요?AnswerSVF·줄기세포 가슴 지방이식은 첨단재생의료에 해당하나요? 병원에서 뭘 확인해야 하나요?Answer「韓国 幹細胞 豊胸」で出てくる幹細胞入り脂肪注入は、普通の脂肪注入と何が違うのですか？Answer日本では幹細胞を使う豊胸に厚生労働省の手続きが必要だと聞きますが、韓国で受ける場合はどう扱われますか？Answer渡韓して脂肪注入豊胸を受ける場合、総額はいくらくらいですか？見積もりで何を確認すべきですか？Answer韩国宣传的“干细胞丰胸”（SVF）和普通自体脂肪丰胸有什么区别？可信吗？Answer赴韩做自体脂肪丰胸大概多少钱？面诊时必须让医院书面确认哪些事？Answerما الفرق بين حقن الدهون العادي وحقن الدهون مع الخلايا الجذعية أو SVF المعروض في بعض عيادات كوريا؟ArticleAutologous Fat: Definition, Composition, Biology, Uses and Safety